Director Gabrielle Sulzberger buys 117 LLY shares at $641.18; 4 other insiders bought in past 14 days amid -33.4% drawdown from 52-week high.
Director Gabrielle Sulzberger purchased 117 shares of Eli Lilly at $641.18 on 2025-08-12, increasing her holdings from 2,586 to 2,703 shares, a +4.5% increase in position size. This buy occurs within a cluster pattern: 4 other insiders also purchased shares within the past 14 days. The transaction takes place as the stock is -33.4% below its 52-week high of $960.02 and has declined -19.4% over the prior 30 days, creating a material price dislocation relative to recent valuations. Given the company's strong fundamentals—$15.6B quarterly revenue, $5.7B net income, and +32.0% annual revenue growth—this synchronized insider buying across multiple parties against a sharp near-term selloff warrants investor attention as a potential indicator of insider assessment of current valuation levels.